nisoldipin effect renin-angiotensin-aldosteron system catecholamin studi normotens hypertens subject effect nisoldipin new calcium channel antagonist renin-angiotensin-aldosteron system plasma catecholamin healthi volunt patient primari essenti hypertens patient thirteen normal renin hypertens nrh sixteen low renin hypertens lrh eight healthi volunt placebo short-term effect subject long-term month effect mg nisoldipin daili hypertens patient plasma renin activ pra rise signific first dose nisoldipin normotens subject hypertens patient pra pre-treat level chang pra administr placebo plasma angiotensin II aii level consider variat nisoldipin administr plasma aldosteron level increas pra aii concentr concomit reduct urinari aldosteron excret plasma noradrenalin level administr nisoldipin chang plasma adrenalin level nisoldipin long-term effect renin-angiotensin-aldosteron system serum catecholamin level 